RhumbLine Advisers’s Harmony Biosciences HRMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.28M	Buy	117,005 +77	+0.1%	+$2.52K	﹤0.01%	1607
2025 Q4	$4.38M	Sell	116,928 -6,061	-5%	-$199K	﹤0.01%	1465
2025 Q3	$3.39M	Buy	122,989 +3,788	+3%	+$130K	﹤0.01%	1622
2025 Q2	$3.77M	Buy	119,201 +10,128	+9%	+$326K	﹤0.01%	1563
2025 Q1	$3.62M	Buy	109,073 +485	+0.4%	+$17.4K	﹤0.01%	1517
2024 Q4	$3.74M	Buy	108,588 +16,537	+18%	+$568K	﹤0.01%	1563
2024 Q3	$3.68M	Sell	92,051 -8,643	-9%	-$304K	﹤0.01%	1584
2024 Q2	$3.04M	Sell	100,694 -3,421	-3%	-$103K	﹤0.01%	1667
2024 Q1	$3.5M	Buy	104,115 +3,570	+4%	+$115K	﹤0.01%	1605
2023 Q4	$3.25M	Sell	100,545 -1,836	-2%	-$51.2K	﹤0.01%	1657
2023 Q3	$3.36M	Buy	102,381 +7,515	+8%	+$261K	﹤0.01%	1578
2023 Q2	$3.34M	Buy	94,866 +10,424	+12%	+$360K	﹤0.01%	1622
2023 Q1	$2.76M	Buy	84,442 +4,557	+6%	+$208K	﹤0.01%	1643
2022 Q4	$4.4M	Buy	79,885 +413	+0.5%	+$22.7K	0.01%	1353
2022 Q3	$3.52M	Buy	79,472 +13,075	+20%	+$638K	0.01%	1437
2022 Q2	$3.24M	Buy	66,397 +7,106	+12%	+$320K	﹤0.01%	1495
2022 Q1	$2.88M	Buy	59,291 +5,702	+11%	+$233K	﹤0.01%	1620
2021 Q4	$2.29M	Buy	53,589 +33,492	+167%	+$1.33M	﹤0.01%	1806
2021 Q3	$770K	Buy	20,097 +1,097	+6%	+$35.3K	﹤0.01%	2347
2021 Q2	$536K	Buy	+19,000	New	+$570K	﹤0.01%	2531